Estrogen receptor-mediated repression of human hepatic lipase gene transcription

Journal of Lipid Research

Volumn 43, Issue 3, 2002, Pages 383-391

  Jones, Daniel R ^a   Schmidt, Robert J ^a   Pickard, Richard T ^a   Foxworthy, Patricia S ^a   Eacho, Patrick I ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

17 estradiol; AP 1; HepG2 cells; Phorbol ester; Promoter Regulation; Very low density apolipoprotein II

Indexed keywords

APOLIPOPROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; OLIGONUCLEOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; TRANSCRIPTION FACTOR AP 1; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL STRAIN HEPG2; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; BINDING SITES; CELL LINE; CHOLESTEROL, HDL; ENZYME REPRESSION; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; LIPASE; LIVER; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0036204085     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hepatic lipase and HDL metabolism
2. The role of hepatic lipase in lipoprotein metabolism
3. Hepatic lipase
4. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates
5. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia
6. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol
7. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population
8. Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activities
9. Influence of high-density lipoprotein cholesterol and rheological factors on the sex difference in cardiovascular disease
10. Role of hepatictriglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women
11. Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus
12. Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity
13. Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes
14. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
15. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins
16. Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse
17. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins: Evidence that hepatic lipase acts as a ligand for lipoprotein uptake
18. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene
19. Variation of postheparin plasma hepatic lipase by menstrual cycle
20. Activities of post-heparin plasma lipoprotein lipase and hepatic endothelial lipase during pregnancy and lactation
21. Oral estrogen replacement therapy in post-menopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate
22. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women
23. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women
24. Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia
25. Development, food intake, and ethinylestradiol influence hepatic triglyceride lipase and LDL-receptor mRNA levels in rats
26. Gene regulation by steroid hormones
27. Regulation of gene expression by nuclear hormone receptors
28. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators
29. Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1
30. Characterization and implications of estrogenic down-regulation of human catachol-O-methyltransferase gene transcription
31. Repression of interleukin-6 gene expression by 17β-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor
32. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing
33. Peroxisome proliferator-activated receptor response specificities as defined in yeast and mammalian cell transcription assays
34. Identification of a cis-acting negative DNA element which modulates human hepatic triglyceride lipase gene expression
35. Transcription of the human hepatic lipase gene is modulated by multiple negative elements in HepG2 cells
36. Differential regulation of hepatic triglyceride lipase and 3-hydroxy-3-methylglutaryl-CoA reductase gene expression in a human hepatoma cell line HepG2
37. Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocyte/macrophages
38. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse
39. A composite regulatory element in the first intron of the estrogen-responsive very low density apolipoprotein II gene
40. Isolation and characterization of clones for the rat hepatic lipase gene upstream regulatory region
41. Structural and functional analysis of the promoter of the hepatic lipase gene
42. Estrogen suppresses transcription of lipoprotein lipase gene
43. Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators
44. Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1
45. The transactivation domain AF-2 but not the DNA-binding domain of the estrogen receptor is required to inhibit differentiation of avian erythroid progenitors
46. Estrogen modulation of apolipoprotein(a) expression
47. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
48. Cross-talk between Stat5b and estrogen receptor-α and β in mammary epithelial cells
49. Agonist-dependent repression mediated by mutant estrogen receptor α that lacks the activation function 2 core domain
50. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway